Johnson & Johnson’s talc liability holding unit said its recently filed bankruptcy case belongs in Texas as a matter of ...

JNJ files for voluntary bankruptcy for the third time. Pfizer withdraws sickle-cell drug drug Oxbryta from worldwide markets.

A batch of votes that enabled Johnson & Johnson to advance its bankruptcy plan for talc lawsuits is disputed by plaintiffs’ ...

The agreement includes "additional monetary and non-monetary benefits for all talc claimants," according to J&J, and takes the proportion backing the settlement above 75% – the threshold needed ...

“Rightly, [IARC] aren’t saying that talc cannot cause ovarian cancer ... With the clock ticking on J&J’s massive settlement plan in the US, it may well be that the IARC’s change will ...

The cuts follow an ongoing wave of staff reductions at big drug companies. Pharma giants have terminated thousands of ...

Johnson & Johnson announced updated results from the investigational Phase 1b TRIMM-2 study evaluating the combination of ...

At least 75% of plaintiffs have reportedly voted in favor of J&J's $6.48 Billion settlement proposal to resolve all talc ovarian cancer claims against them. This was the level of support needed to ...

Jayson Ruff, a trial attorney for U.S. Trustee Kevin Epstein in Houston, filed the venue motion on Thursday, two days after a ...

New York Catholic diocese reaches $323 mln sex abuse settlement A Roman Catholic diocese ... A New Jersey judge said on Tuesday that Johnson & Johnson's talc subsidiary may pursue bankruptcy ...